Literature DB >> 31085174

The Fire within: Cell-Autonomous Mechanisms in Inflammation-Driven Cancer.

Jelena Todoric1, Michael Karin2.   

Abstract

Inflammatory cells are important for tumor initiation and promotion, providing cancer cells with cytokines that enhance cell proliferation and survival. Although malignant epithelial cells were traditionally considered to be on the receiving end of these microenvironmental interactions, recent studies show that epithelial cells can undergo inflammatory reprogramming on their own. Such epigenetic switches are often triggered by chronic tissue injury and play important roles in tissue repair. By converting terminally differentiated cells that harbor even a single oncogenic mutation to a less differentiated state with a higher proliferative potential, cell-autonomous inflammation is an important contributor to tumor initiation.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  cancer; inflammation; inflammatory memory; transcriptional switch

Mesh:

Year:  2019        PMID: 31085174     DOI: 10.1016/j.ccell.2019.04.001

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  15 in total

1.  TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancer.

Authors:  Mengyu Tu; Lukas Klein; Elisa Espinet; Theodoros Georgomanolis; Florian Wegwitz; Xiaojuan Li; Laura Urbach; Adi Danieli-Mackay; Stefan Küffer; Kamil Bojarczuk; Athanasia Mizi; Ufuk Günesdogan; Björn Chapuy; Zuguang Gu; Albrecht Neesse; Uday Kishore; Philipp Ströbel; Elisabeth Hessmann; Stephan A Hahn; Andreas Trumpp; Argyris Papantonis; Volker Ellenrieder; Shiv K Singh
Journal:  Nat Cancer       Date:  2021-11-15

2.  Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate pancreatic cancer.

Authors:  Yong Li; Yi He; Junya Peng; Zhendong Su; Zeyao Li; Bingjie Zhang; Jing Ma; Meilian Zhuo; Di Zou; Xinde Liu; Xinhong Liu; Wenze Wang; Dan Huang; Mengyue Xu; Jianbin Wang; Haiteng Deng; Jing Xue; Wei Xie; Xun Lan; Mo Chen; Yupei Zhao; Wenming Wu; Charles J David
Journal:  Nat Cancer       Date:  2020-11-02

3.  Heterogeneous phenotypes of Pten-null hepatocellular carcinoma in hepatitis B virus transgenic mice parallels liver lobule zonal gene expression patterns.

Authors:  Claudia E Oropeza; Caitlin R Ondracek; Grant Tarnow; Mark Maienschein-Cline; Stefan J Green; Alan McLachlan
Journal:  Virology       Date:  2021-11-23       Impact factor: 3.616

4.  Betanin purification from red beetroots and evaluation of its anti-oxidant and anti-inflammatory activity on LPS-activated microglial cells.

Authors:  Hosein Ahmadi; Zahra Nayeri; Zarrin Minuchehr; Farzaneh Sabouni; Mehdi Mohammadi
Journal:  PLoS One       Date:  2020-05-13       Impact factor: 3.240

Review 5.  Predisposition to Apoptosis in Hepatocellular Carcinoma: From Mechanistic Insights to Therapeutic Strategies.

Authors:  Jens U Marquardt; Frank Edlich
Journal:  Front Oncol       Date:  2019-12-13       Impact factor: 6.244

Review 6.  Natural Products in the Prevention of Metabolic Diseases: Lessons Learned from the 20th KAST Frontier Scientists Workshop.

Authors:  Seung J Baek; Bruce D Hammock; In-Koo Hwang; Qingxiao Li; Naima Moustaid-Moussa; Yeonhwa Park; Stephen Safe; Nanjoo Suh; Sun-Shin Yi; Darryl C Zeldin; Qixin Zhong; Jennifer Alyce Bradbury; Matthew L Edin; Joan P Graves; Hyo-Young Jung; Young-Hyun Jung; Mi-Bo Kim; Woosuk Kim; Jaehak Lee; Hong Li; Jong-Seok Moon; Ik-Dong Yoo; Yiren Yue; Ji-Young Lee; Ho-Jae Han
Journal:  Nutrients       Date:  2021-05-31       Impact factor: 5.717

7.  Downregulation of m6 A writer complex member METTL14 in bladder urothelial carcinoma suppresses tumor aggressiveness.

Authors:  Catarina Guimarães-Teixeira; João Lobo; Vera Miranda-Gonçalves; Daniela Barros-Silva; Cláudia Martins-Lima; Sara Monteiro-Reis; José Pedro Sequeira; Isa Carneiro; Margareta P Correia; Rui Henrique; Carmen Jerónimo
Journal:  Mol Oncol       Date:  2022-03-24       Impact factor: 7.449

8.  Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy.

Authors:  Chunai Gong; Xiaoyan Yu; Benming You; Yan Wu; Rong Wang; Lu Han; Yujie Wang; Shen Gao; Yongfang Yuan
Journal:  J Nanobiotechnology       Date:  2020-06-16       Impact factor: 10.435

Review 9.  MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer.

Authors:  Jaslin P James; Lene Buhl Riis; Mikkel Malham; Estrid Høgdall; Ebbe Langholz; Boye S Nielsen
Journal:  Int J Mol Sci       Date:  2020-10-24       Impact factor: 5.923

Review 10.  The updated landscape of tumor microenvironment and drug repurposing.

Authors:  Ming-Zhu Jin; Wei-Lin Jin
Journal:  Signal Transduct Target Ther       Date:  2020-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.